新颖取代1,3,5-三嗪候选分子的合理设计及其作为高选择性双重IDH1(R132H)/IDH2(R140Q)抑制剂的研宄，针对急性髓系白血病的体内外前临床研究
Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations
DOI 原文链接
用sci-hub下载
如无法下载，请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2024 Aug
作者:
DOI:10.1016/j.bioorg.2024.107483
摘要
AI正在翻译并加载中文摘要...